to maximize their impact on human health
needed to solve medicine's most challenging problems
meaningful clinical benefit and growing further discovery
The Latest News
-
Over the last decade, his publications are among the top 1% in the world by number of citations. -
In the News
Cellomm.org Interview with Erkki Ruoslahti
Cellcomm Interviews with Experts: Giovanni Paternostro interview with Erkki Ruoslahti -
Drug Discovery
Sanford Burnham Prebys selected for participation in National Cancer Institute Chemical Biology Consortium
For the third time, Sanford Burnham Prebys has been selected by the National Cancer Institute as a Center for the Chemical Biology Consortium (CBC). -
New funding will allow Institute faculty to explore bold new avenues for addressing some of the world’s toughest cancers -
Immunity
Yasuyuki Kihara wins a dream award
Research Assistant Professor Yasuyuki Kihara, Ph.D., has won an Eicosanoid Research Foundation (ERF) Young Investigator Award, an award for researchers working in lipid biology. -
A new flow cytometer at the Institute will help researchers study the immune system with unprecedented resolution and speed. -
Sanford Burnham Prebys has partnered with more than 50 cancer organizations to issue a call to action promoting more thorough screening for lung cancer, the leading cause of cancer death in the United States. -
Children's Health
Research unlocks the circuitry of diabetes
Inflammation rewires our cells – and this leads to one of the deadliest chronic diseases -
Community
Thank you, Jim Blair!
Last month, our incredibly dedicated Board Chair, James C. Blair, Ph.D., stepped down after four years of fearless leadership. -
The award honors the late postdoctoral researcher Eric Dudl, who devoted the last years of his life to cancer research -
Since 2001, the awards have paid tribute to our Institute’s heritage and supported the trailblazers of tomorrow -
Since 2020, Todd and Rena Johnson have helped fund the research of Associate Professor Ani Deshpande, Ph.D. But it all started with their son Luke.
Living History
NCI-Designated Cancer Center
Earning the NCI designation in 1981 — just five years after its modest start in downtown La Jolla — our Cancer Center truly is "the miracle on Torrey Pines Mesa."
Next Generation
Svasti Haricharan and Brooke Emerling featured in GEN
Svasti Haricharan, Ph.D. and Brooke Emerling, Ph.D. are leveraging cellular signaling to potentially change the way we treat breast cancer.
Living History
Along the road to discovery
It was in 1979 when Eva Engvall asked Erkki Ruoslahti a question that would change their lives forever: "Wouldn't it be great to work in San Diego?"
Next Generation
Graduate student Katja Birker's research doesn't miss a beat
"There is no magic wand to cure congenital heart conditions–we have to do the research."
Our Partners in Discovery
We can't do it alone
Our annual Rare Disease Day symposium strengthens the global network of families, physicians and researchers to better understand and fight rare diseases in children.
Our Partners in Discovery
Getting to the finish line faster
Thanks to the philanthropic vision of Stuart and Karen Tanz, a unique collaboration seeks new treatments for diseases such as Alzheimer’s, dementia and Parkinson’s.
Our Partners in Discovery
New hope for autoimmune disease
Our partnership with Lilly—centered around a high degree of interaction—has already produced an immune therapy now in clinical trial.
Our Partners in Discovery
A master class in collaboration
Meet T. Denny Sanford, Conrad Prebys and Malin Burnham: three people who know we're stronger when we work together.
